Home

Site Map

Appointments

Second Opinions

Glossary

Links

Giving

Joseph Herman, M.D., M.Sc.

Johns Hopkins Medical Institution
Weinberg 1440 - Oncology
401 North Broadway
Baltimore, MD 21231
Email: jherma15@jhmi.edu
Phone: (410) 955-7313  Fax: (410) 502-1419
Website: www.radonc.jhmi.edu

Position and Honors

Year	Position/Employment
2001	Internship, Internal Medicine, University of Michigan Health System
2001-2005	Residency, Department of Radiation Oncology, University of Michigan Health System
2003-2004	Principal Investigator, Department of Radiation Oncology, University of Michigan Health System
2004-2005	Chief Resident, University of Michigan Health System
2005-	Instructor, Department of Radiation Oncology, Johns Hopkins University

Year	Honors
1994	Letter of Commendation, National Institutes of Health, Neurogenetics Section
1994-1995	Selected Male Scholar/Athlete of the Year
1995	Graduate Merit Award, UMAB Master of Science in Preventive Medicine
1997	Awarded STRTP NIH grant to develop an IFA assay for HHV-8 and Kaposi's Sarcoma
2000	Outstanding Student Achievement Award in Radiation Oncology and Pathology
2001	Awarded Intern of the Month, University of Michigan Internal Medicine
2005	Awarded RSNA Resident of the Year, University of Michigan Radiation Oncology

Selected References:
Publications
1. Tayebi N, Herman J, et al. Different recombinational events between the GC gene and pseudogene in patients with type 1, 2, and 3 Gaucher disease. A J Hum Genet. 1995; 57(4):1329.

2. Sidransky E, Tayebi N, Herman J, et al. Genotypic and phenotypic heterogeneity in type 2 Gaucher disease. Am J Hum Genet. 1995; 57(4):1453.

3. Tayebi N, Stern H, Dymarskaia I, Herman J, et al. 55 Base pair deletion in certain patients with Gaucher disease complicates screening for Gaucher alleles. Am J Med Genet. 1996; 66:316-319.

4. Tayebi N, Herman J, et al. Genotype D399/R463C in a patient with type 3 Gaucher disease previously assigned genotype N370/R463C. Biochem Mol Med. 1996; 57:149-151.

5. Solomon G, Huddle A, Silbergeld E, Herman J. Manganese in Gasoline: Are we repeating history? New Solutions. 1997; Winter:17-24.

6. Edelman D, Ketema F, Saville R, Herman J, Blattner W, et al. Specifics on the refinement and application of two serological assays for the detection of antibodies to HHV-8. J. Clinical Virology. 2000; 16(3):225-37.

7. Suntharalingam M.H., Conley M.L., Egorin B.A., Levy M.H., Sivasailam S., Herman J.M., et al. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2000; 47(1):49-56.

8. Nwokedi E.C., DiBiase S.J., Jabbour S, Herman J, et al. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery. 2002; 50(1):41-46.

9. Petit J, Herman J, et al. Radiosurgical treatment of trigeminal neuralgia: evaluating quality of life and treatment outcomes. Int J Radiat Oncol Biol Phys. 2003; 56(4):1147-53.

10. Herman J, Smith D, Sandler H, et al. Quality of Life (QOL) assessment in patients receiving concurrent Gemcitabine and radiotherapy as a bladder preservation strategy. Urology. 2004; Jul 64(1):69-73.

11. Herman J, Petit J, et al. Repeat Gamma Knife Radiosurgery for Refractory or Recurrent Trigeminal Neuralgia: Treatment Outcomes and Quality of Life Assessment. Int J Rad Oncol Biol Phys. 2004; 59(1):112-116.

12. Kent E, Montie J, Lee C, Sandler H, Herman J, et al. Combined-modality therapy with Gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial. J Clin Oncol. 2004; Jul 22(13):2540-5.